These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
807 related articles for article (PubMed ID: 25978975)
21. Recurrence after sentinel lymph node biopsy in cutaneous melanoma: a single-center experience in Slovak patients. Sabol M; Reken V; Sabolova L; Waczulikova I; Donat R; Dyttert D; Chvalny P; Durdik S Neoplasma; 2019 Jul; 66(4):647-651. PubMed ID: 31058535 [TBL] [Abstract][Full Text] [Related]
22. The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma. Bello DM; Han G; Jackson L; Bulloch K; Ariyan S; Narayan D; Rothberg BG; Han D Ann Surg Oncol; 2016 Dec; 23(Suppl 5):938-945. PubMed ID: 27527717 [TBL] [Abstract][Full Text] [Related]
23. Is there a relation between type of primary melanoma treatment and the development of intralymphatic metastasis? A review of the literature. Sloot S; Speijers MJ; Bastiaannet E; Hoekstra HJ Cancer Treat Rev; 2016 Apr; 45():120-8. PubMed ID: 27015564 [TBL] [Abstract][Full Text] [Related]
24. Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2). Broman KK; Hughes T; Dossett L; Sun J; Kirichenko D; Carr MJ; Sharma A; Bartlett EK; Nijhuis AAG; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma JM; Deneve JL; Fleming MD; Perez MC; Lowe MC; Olofsson Bagge R; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras J; Teras RM; Farrow NE; Beasley G; Hui JYC; Been L; Kruijff S; Kim Y; Naqvi SMH; Sarnaik AA; Sondak VK; Zager JS Cancer; 2021 Jul; 127(13):2251-2261. PubMed ID: 33826754 [TBL] [Abstract][Full Text] [Related]
25. Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanoma. Yamamoto M; Fisher KJ; Wong JY; Koscso JM; Konstantinovic MA; Govsyeyev N; Messina JL; Sarnaik AA; Cruse CW; Gonzalez RJ; Sondak VK; Zager JS Cancer; 2015 May; 121(10):1628-36. PubMed ID: 25677366 [TBL] [Abstract][Full Text] [Related]
26. Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax. Wagner JD; Park HM; Coleman JJ; Love C; Hayes JT Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):313-21. PubMed ID: 10722003 [TBL] [Abstract][Full Text] [Related]
27. Sentinel Lymph Node Biopsy Provides Prognostic Value in Thick Head and Neck Melanoma. Monroe MM; Pattisapu P; Myers JN; Kupferman ME Otolaryngol Head Neck Surg; 2015 Sep; 153(3):372-8. PubMed ID: 26070510 [TBL] [Abstract][Full Text] [Related]
28. Completion lymph node dissection in patients with sentinel lymph node positive cutaneous head and neck melanoma. Huang K; Misra S; Lemini R; Chen Y; Speicher LL; Dawson NL; Tolaymat LM; Bagaria SP; Gabriel EM J Surg Oncol; 2020 Nov; 122(6):1057-1065. PubMed ID: 32654173 [TBL] [Abstract][Full Text] [Related]
29. Interventions for Old World cutaneous leishmaniasis. Heras-Mosteiro J; Monge-Maillo B; Pinart M; Lopez Pereira P; Reveiz L; Garcia-Carrasco E; Campuzano Cuadrado P; Royuela A; Mendez Roman I; López-Vélez R Cochrane Database Syst Rev; 2017 Nov; 11(11):CD005067. PubMed ID: 29149474 [TBL] [Abstract][Full Text] [Related]
30. Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node. Leiter U; Stadler R; Mauch C; Hohenberger W; Brockmeyer NH; Berking C; Sunderkötter C; Kaatz M; Schatton K; Lehmann P; Vogt T; Ulrich J; Herbst R; Gehring W; Simon JC; Keim U; Verver D; Martus P; Garbe C; J Clin Oncol; 2019 Nov; 37(32):3000-3008. PubMed ID: 31557067 [TBL] [Abstract][Full Text] [Related]
31. The optimum excision margin and regional node management for primary cutaneous T3 melanomas (2-4 mm in Thickness): a retrospective study of 1587 patients treated at a single center. Lamboo LG; Haydu LE; Scolyer RA; Quinn MJ; Saw RP; Shannon KF; Spillane AJ; Stretch JR; Bonenkamp JJ; Thompson JF Ann Surg; 2014 Dec; 260(6):1095-102. PubMed ID: 25072430 [TBL] [Abstract][Full Text] [Related]
32. Completion Lymph Node Dissection Based on Risk of Nonsentinel Metastasis in Cutaneous Melanoma of the Head and Neck. Fritsch VA; Cunningham JE; Lentsch EJ Otolaryngol Head Neck Surg; 2016 Jan; 154(1):94-103. PubMed ID: 26399717 [TBL] [Abstract][Full Text] [Related]
33. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma. Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497 [TBL] [Abstract][Full Text] [Related]
34. Lymphadenectomy for the management of endometrial cancer. Frost JA; Webster KE; Bryant A; Morrison J Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD007585. PubMed ID: 26387863 [TBL] [Abstract][Full Text] [Related]
35. National Practice Patterns in the Management of the Regional Lymph Node Basin After Positive Sentinel Lymph Node Biopsy for Cutaneous Melanoma. Sharon CE; Straker RJ; Li EH; Karakousis GC; Miura JT Ann Surg Oncol; 2022 Dec; 29(13):8456-8464. PubMed ID: 36006494 [TBL] [Abstract][Full Text] [Related]
36. Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients. Gutzmer R; Al Ghazal M; Geerlings H; Kapp A Br J Dermatol; 2005 Dec; 153(6):1137-41. PubMed ID: 16307648 [TBL] [Abstract][Full Text] [Related]
37. Sentinel lymph node biopsy plus wide local excision vs. wide location excision alone for primary cutaneous melanoma: a systematic review and meta-analysis. Santos-Juanes J; Fernández-Vega I; Galache Osuna C; Coto-Segura P; Martínez-Camblor P J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):241-246. PubMed ID: 27592851 [TBL] [Abstract][Full Text] [Related]